3651 results for «249»
3651 results
Diversity in coronary artery disease treatment
22 May 2026 – From EuroPCR 2026
Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis...
The microcirculation: the next frontier in coronary practice
18 May 2026 – From EuroPCR 2026
Delve into the complexities of coronary microcirculation and its clinical implications. This session highlighted advanced diagnostic techniques such as bolus and continuous thermodilution, the interpretation of microvascular resistance reserve, and practical guidance on establishing a high-impact ANOCA clinic to manage microvascular angina and coronary dysfunction.
News from drug-eluting therapies in 2026
19 May 2026 – From EuroPCR 2026
This session presents the latest advancements in drug-eluting therapies for 2026, including predictors of target lesion failure after drug-coated balloon treatment, clinical outcomes related to stenting length, and novel insights into sirolimus transfer evidenced by in vivo OCT imaging.
TAVI complications: impact and improvement
20 May 2026 – From EuroPCR 2026
This session examines critical complications associated with TAVI and strategies to mitigate their impact. Topics include carbon-dioxide flushing to reduce brain injury, management of cardiac tamponade, AI-driven customization of TAVI in complex anatomies, and the influence of vascular complications on post-procedural quality of life.
INOCA/ANOCA: technical aspects
20 May 2026 – From EuroPCR 2026
This session covers technical aspects critical to the evaluation and management of ischemia with non-obstructive coronary arteries (INOCA) and angina with non-obstructive coronary arteries (ANOCA). Key topics include the impact of guide catheter shape, injection techniques for thermodilution measurements, advanced perfusion CMR diagnostics, and the physiological...
Continual refinement in LAA closure
20 May 2026 – From EuroPCR 2026
This session presents the latest advancements in left atrial appendage closure (LAAC). It covers new risk scoring systems, sex-specific outcome analyses, safety in elderly populations, and comparative data between LAMBRE and WATCHMAN devices from a high-volume center, highlighting continual refinement in LAAC strategies.
CTO ADVANCED Level III: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland
21 May 2026 – From EuroPCR 2026
This advanced educational session features live complex chronic total occlusion (CTO) PCI cases from Institut Cardiovasculaire Paris Sud and University Hospital Basel. It emphasizes optimizing strategy selection, procedural efficiency across diverse CTO anatomies, and integrating advanced techniques into routine complex practice.
CTO ADVANCED Level I: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland
21 May 2026 – From EuroPCR 2026
This advanced level I CTO session features live educational cases from Institut Cardiovasculaire Paris Sud and University Hospital Basel, focusing on structured procedure analysis, imaging-based planning, and integrated CTO techniques. Detailed case presentations and live procedural demonstrations underscore strategies for success in complex CTO interventions.
REVIVED-BCIS2: no benefit of routine PCI in patients with reduced LVEF
13 Mar 2023
Dejan Milasinovic provides his take on the REVIVED trial - percutaneous revascularisation for ischaemic ventricular dysfunction, which was presented during ESC Congress 2022 in Barcelona.
Author
Why hypertension is a major unresolved problem
02 Oct 2024
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.
Author
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation - the OPTION Trial
17 Nov 2024
Alessandro Sticchi provides his take on the OPTION Trial presented at AHA 2024 in Chicago.
Author
